Table 3 Sensitivity, specificity, positive and negative predictive value of low podoplanin expression to predict tumor progression/recurrence and poor overall outcome (dying from disease) in cervical squamous cell carcinomas
Sensitivity | Specificity | PPV | NPV | RR (95% CI) | |
---|---|---|---|---|---|
All cases (series A and B) combined | |||||
Recurrence | 0.5294 | 0.7692 | 0.7500 | 0.5556 | 1.69 (1.24–2.30) |
Dying from disease | 0.3676 | 0.9231 | 0.8621 | 0.5275 | 1.82 (1.41–2.37) |
Advanced stage cases treated by primary radiation | |||||
Recurrence | 0.6579 | 0.6765 | 0.6944 | 0.6389 | 1.92 (1.18–3.13) |
Dying from disease | 0.5526 | 0.8824 | 0.8400 | 0.6383 | 2.32 (1.53–3.52) |